Market Moves
Weiling Medical raises over RMB 100 million for its surface-electrode brain implant
Shenzhen's Weiling Medical Technology closed a new funding round of over RMB 100 million on 17 August 2026, led by Junzhong Capital with STAR Market-listed Innotek (688253.SH) as core industrial investor via the Jiaxing Innotek Industrial Fund. Weiling develops a fully implantable, flexible thin-film cortical electrode that sits on the cortical surface rather than penetrating brain tissue. A first-in-human implant in Guangdong in mid-June 2026 was reported by the company to restore forearm and wrist movement in the left upper limb of a locked-in syndrome patient.